Skip to main content
. 2017 Sep 30;8(55):93942–93956. doi: 10.18632/oncotarget.21397

Figure 3. Survival analysis for the total group of patients prior to stage classification.

Figure 3

(A) Survival prediction model for the total group of patients prior to stage classification, developed by multivariable Cox regression analysis using backward stepwise selection. Patients in risk group 2, risk group 3 and risk group 4 had a HR of 2.65 (95% CI; 1.24-5.66), 4.34 (95% CI; 1.98-9.51) and 21.19 (95% CI; 8.61-52.15), respectively, compared to risk group 1. (B) The gene combination together with the corresponding the HR is illustrated for the survival prediction model (ASA=3, BNC1, GSTP1, TFPI2, SFRP1, and SFRP2). Blue: Risk group 1. Red: Risk group 2. Green: Risk group 3. Yellow: Risk group 4. Note: Stage is in accordance with The American Joint Committee on Cancer stage classification.